Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder
Authors:
- Norman ZinnerNZNorman Zinner
- John TuttleJTJohn Tuttle
- 12 August 2005
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 23 (4) , 248-252
Abstract
A randomized, double-blind, placebo-controlled, four-way crossover, safety study of darifenacin versus oxybutynin was carried out on 76 patients with overactive bladder (OAB). Adults with OAB received 2 weeks each of darifenacin 15 and 30 mg once daily (q.d.), oxybutynin 5 mg three times daily (t.i.d.) and placebo, in random sequence at 10-day intervals. Darifenacin and oxybutynin significantly reduced incontinence episodes, and the number/severity of urgency episodes (all P P<0.05), while constipation was comparable (10% and 8%, respectively). Corresponding rates for darifenacin 30 mg were 34% and 21%, respectively. Patients only reported blurred vision or dizziness with oxybutynin (3% and 2%, respectively). Darifenacin (15 mg q.d.) provides comparable efficacy with improved tolerability versus oxybutynin (5 mg t.i.d.) in the treatment of patients with OAB.Keywords
This publication has 20 references indexed in Scilit:
- ASSESSMENT OF COGNITIVE FUNCTION OF THE ELDERLY POPULATION: EFFECTS OF DARIFENACINJournal of Urology, 2005
- Darifenacin, an M3 Selective Receptor Antagonist, is an Effective and Well-Tolerated Once-Daily Treatment for Overactive BladderEuropean Urology, 2004
- Transient Memory Impairment and Hallucinations Associated with Tolterodine UseNew England Journal of Medicine, 2003
- Potential Benefits of Muscarinic M3 Receptor SelectivityEuropean Urology Supplements, 2002
- M3 muscarinic receptors mediate contraction of human urinary bladderBritish Journal of Pharmacology, 2002
- The minor population of M3‐receptors mediate contraction of human detrusor muscle in vitroJournal of Autonomic Pharmacology, 2001
- The overactive bladderBJU International, 2001
- Lesson of the week: Oxybutynin and cognitive dysfunctionBMJ, 1997
- A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder complianceBJOG: An International Journal of Obstetrics & Gynaecology, 1997
- Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivoBritish Journal of Pharmacology, 1997